At ₹49 per tablet, Lupin launches Covihalt for covid treatment
Bengaluru: Pharma major Lupin Ltd on Wednesday announced the launch of Favipiravir in India under the brand name Covihalt for treatment of mild to moderate COVID-19.Favipiravir has received authorisation from the Drug Controller!-->!-->!-->!-->!-->…
Read More...
Read More...